Machine-learning screening yields novel potent acetylcholinesterase and butyrylcholinesterase inhibitors
NCATS researchers trained machine-learning QSAR models and applied them to a roughly 360,000-compound library. Experimental colorimetric and orthogonal fluorescence assays confirmed new AChE/BChE inhibitors; the study reports 22 AChE and 67 BChE inhibitors with IC50 below 5 μM, including novel structural series, with some submicromolar compounds.
Technology: Ensemble comparison of machine-learning QSAR classifiers (including XGBoost, random forest, SVM, neural network and naïve Bayes)
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Experimental colorimetric and orthogonal fluorescence assays confirmed new AChE/BChE inhibitors; the study reports 22 AChE and 67 BChE inhibitors with IC50 below 5 μM, including novel structural series, with some submicromolar compounds.
- Still unknown: These are biochemical inhibitor assays and early medicinal-chemistry leads; they do not establish brain exposure, in-vivo efficacy, safety or clinical benefit. Several known compounds were newly identified as inhibitors, so the count of all assay hits should not be described as entirely novel molecules.
- AI role: Models trained on quantitative high-throughput screening data prioritized compounds in a ~360,000-compound collection for AChE/BChE inhibition and selectivity assays. Researchers tested 2,762 high-scoring compounds in colorimetric assays and used an orthogonal fluorescence assay to confirm predicted inhibitors; subsequent structure–activity analysis identified novel scaffolds.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10688023/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 26 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.